Lipoprotein(a) Clinical Trials in Lodz
2 recruitingLodz, Poland
Showing 1–2 of 2 trials
Recruiting
Phase 3
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals5,700 enrolled618 locationsNCT07517263
Recruiting
The Prevalence of Hyper-Lp(a)-Emia in the PMMHRI-Lp(a) Registry
Lipoprotein(a), Hyper-Lp(a)-Emia
Polish Mother Memorial Hospital Research Institute2,000 enrolled1 locationNCT06610669